Aracmyn

· Instituto Bioclon S.A. de C.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aracmyn, covering 2016-03-22 to 2016-03-22. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of Aracmyn in Patients With Systemic Latrodectism [Phase 2]